Equities

Bergenbio ASA

Bergenbio ASA

Actions
  • Price (NOK)8.80
  • Today's Change8.80 / --
  • Shares traded2.20k
  • 1 Year change-24.02%
  • Beta--
Data delayed at least 20 minutes, as of Sep 09 2024 13:52 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in NOKIncome statement in NOKView more

Year on year Bergenbio ASA had revenues fall -9.00% from 389.00k to 354.00k, though the company grew net income from a loss of 302.12m to a smaller loss of 190.40m.
Gross margin--
Net profit margin-29,828.21%
Operating margin-31,124.18%
Return on assets-67.73%
Return on equity-85.55%
Return on investment-85.55%
More ▼

Cash flow in NOKView more

In 2023, Bergenbio ASA did not generate a significant amount of cash. Cash Flow from Financing totalled 224.88m or 63,526.55% of revenues. In addition the company used 225.10m for operations while cash from investing totalled 3.06m.
Cash flow per share-5.37
Price/Cash flow per share--
Book value per share4.48
Tangible book value per share4.48
More ▼

Balance sheet in NOKView more

Bergenbio ASA appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio5.05
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.